TAK

Takeda PharmaceuticalC

NYSE / Pharmaceuticals, Biotechnology & Life Sciences

Quote time unavailable

View Chart

Peers tracked

U.S. public peers

Grade Position

Below peers

vs peer average

TAK vs peer average

40/100

TAK vs. peer average (C vs. B)

Grade spread

A 2 · B 5 · C 3 · F 1

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

NVS is the first available peer comparator.

Diversified, big-pharma peer with sizeable OTC/innovator balance; similar exposure to regulatory and emerging-market dynamics.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerNVSNovartis

TAK

Takeda Pharmaceutical

NVS

Novartis

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Mixed

Constructive

Open Side-by-Side Comparison Compare all

Grade position vs NVS

TAK / NVS

Grade Position

Below peers

TAK vs. peer average (C vs. B)

40/100

Momentum

TAK

Value

TAK

Sentiment

NVS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs TAK

NVS

80/100

-1

PFE

80/100

-1

SNY

100/100

-2

ARGX

argenx SE ADR

60/100

Even

RVMD

Revolution Medicines Inc Common

20/100

NVS is the first peer returned for this comparison set.